Measles - The epidemiology of elimination

被引:87
作者
Durrheim, David N. [1 ]
Crowcroft, Natasha S. [2 ,3 ,4 ]
Strebel, Peter M. [5 ]
机构
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2287, Australia
[2] Publ Hlth Ontario, Toronto, ON, Canada
[3] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[4] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[5] WHO, Expanded Programme Immunizat, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland
关键词
Measles; Elimination; Western Pacific; Americas; Epidemiology; UNITED-STATES; TRANSMISSION; CHALLENGES; SETTINGS; PROGRESS;
D O I
10.1016/j.vaccine.2014.10.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tremendous progress has been made globally to reduce the contribution of measles to the burden of childhood deaths and measles cases have dramatically decreased with increased two dose measles-containing vaccine coverage. As a result the Global Vaccine Action Plan, endorsed by the World Health Assembly, has targeted measles elimination in at least five of the six World Health Organisation Regions by 2020. This is an ambitious goal, since measles control requires the highest immunisation coverage of any vaccine preventable disease, which means that the health system must be able to reach every community. Further, while measles remains endemic in any country, importations will result in local transmission and outbreaks in countries and Regions that have interrupted local endemic measles circulation. One of the lines of evidence that countries and Regions must address to confirm measles elimination is a detailed description of measles epidemiology over an extended period. This information is incredibly valuable as predictable epidemiological patterns emerge as measles elimination is approached and achieved. These critical features, including the source, size and duration of outbreaks, the seasonality and age-distribution of cases, genotyping pointers and effective reproduction rate estimates, are discussed with illustrative examples from the Region of the Americas, which eliminated measles in 2002, and the Western Pacific Region, which has established a Regional Verification Commission to review progress towards elimination in all member countries. Crown Copyright (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:6880 / 6883
页数:4
相关论文
共 40 条
[1]  
Anderson RM, 2005, INFECT DIS HUMANS
[2]  
[Anonymous], 2013, Wkly Epidemiol Rec, V88, P89
[3]  
[Anonymous], 2014, Wkly Epidemiol Rec, V89, P45
[4]  
[Anonymous], 2009, RESP MEASL OUTBR MEA
[5]  
[Anonymous], 2013, VACCINE, V31, pS5
[6]   Biological feasibility of measles eradication [J].
Bellini, William J. ;
Rota, Paul A. .
VIRUS RESEARCH, 2011, 162 (1-2) :72-79
[7]   Estimating the measles effective reproduction number in Australia from routine notification data [J].
Chiew, May ;
Gidding, Heather F. ;
Dey, Aditi ;
Wood, James ;
Martin, Nicolee ;
Davis, Stephanie ;
McIntyre, Peter .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2014, 92 (03) :171-177
[8]   Outbreak of Measles in the Republic of Korea, 2007: Importance of Nosocomial Transmission [J].
Choi, Won Suk ;
Sniadack, David H. ;
Jee, Youngmee ;
Go, Un-Yeong ;
So, Jae Sung ;
Cho, Heeyeon ;
Bae, Geun-Ryang ;
Lee, Dong Han ;
Kim, Kisoon ;
Yoon, Hee Sook ;
Chung, Yoon Seok ;
Kang, Chun ;
Park, Hyekyung ;
Park, Ok ;
Lee, Jong Koo .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 :S483-S490
[9]   The potential for measles transmission in England [J].
Choi, Yoon Hong ;
Gay, Nigel ;
Fraser, Graham ;
Ramsay, Mary .
BMC PUBLIC HEALTH, 2008, 8 (1)
[10]  
De Serres G, 2000, AM J EPIDEMIOL, V151, P1039, DOI 10.1093/oxfordjournals.aje.a010145